Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthetic Biologics Inc.

www.syntheticbiologics.com

Latest From Synthetic Biologics Inc.

War on C Difficile Is Being Fought On Multiple Fronts

Pivotal trials are underway for two microbiota restoration therapies, a narrow-spectrum antibiotic and a vaccine; funding from non-profits and new owners have revived stalled projects at Summit, Deinove and MGB Biopharma.

Infectious Diseases Research & Development

Breakthrough Designation Rescissions: Who Might US FDA Drop Next?

Our chart details the pipeline candidates who might lose the coveted status as treatment paradigms change and trial results come in.
Review Pathway Drug Review

Keeping Track: CDER Approves Its First Two Novel Agents Of 2019

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Microbiome, Clinical Trial Enrichment Among Question Marks As US FDA Weighs Guidance On Non-Traditional Infectious Disease Treatment

Discussions among panelists at US FDA meeting reveal lack of consensus in many key areas. 

Research & Development Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Pipex Therapeutics Inc.
  • Pipex Pharmaceuticals Inc.
  • Sheffied Pharmaceuticals Inc.
  • Adeona Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synthetic Biologics Inc.
  • Senior Management
  • Steven Shallcross, Interim CEO & CFO
    Michael Kaleko, MD, PhD, SVP, R&D
    Joseph Sliman, MD, CMO
  • Contact Info
  • Synthetic Biologics Inc.
    Phone: (301) 417-4364
    9605 Medical Center Dr., Ste. 270
    Rockville, MD 20850
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register